Targeting one-carbon metabolism by methyl donors for prevention of non-alcoholic fatty liver in rats

被引:0
|
作者
Al Doghaither, Huda Abdulaziz [1 ]
机构
[1] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia
来源
关键词
One-Carbon Metabolism; L-Methionine; Choline; Folic Acid; Methyl Donors; BIOMARKERS; DISEASE;
D O I
10.4328/ACAM.21802
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: The purpose of the current work was to demonstrate and compare the impacts of folate, methionine, and choline as methyl donors in the prevention of NAFLD induced by a high-fructose diet (HFrD). Material and Methods: Sixty adult male albino rats were divided into five groups: G1 had a control-fed basal diet; in G2, the rats were fed an HFrD containing 45% fructose (HFrD); in G3, G4, and G5, the rats were fed an HFrD supplemented with folic acid, L-methionine, and choline chloride, respectively. The present study's findings showed a close connection between methyl donors and lipid metabolism. Results: The findings indicated that the folic acid supplemented diet (HFrD+ folate) exhibited the most substantial improvement in hepatic total lipids (TP), triacylglycerol (TG), phospholipid (PL), serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), free fatty acid (FFA), albumin (ALB), total bile acid (TBA), fasting blood glucose (FBG), proinflammatory cytokines levels, and enzyme activities of alanine transaminase (ALT), aspartate transaminase (AST), fatty acid synthase (FAS), and acetyl coenzyme A carboxylase (ACC). In the same context, L-methionine had the most significant improvement in oxidative stress biomarker (glutathione [GSH], superoxide dismutase [SOD], 4-hydroxynonenal [4-HNE]) levels, followed by folic acid and choline. Discussion: Methyl donors such as folic acid, methionine, and choline are essential for maintaining OCM and can prevent animals with NAFLD from developing liver lipid accumulation.
引用
收藏
页码:830 / 834
页数:5
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease
    Smith, Briohny W.
    Adams, Leon A.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2011, 48 (03) : 97 - 113
  • [42] Fatty Liver and Non-Alcoholic Steatohepatitis
    Saito, Takafumi
    Misawa, Keiko
    Kawata, Sumio
    INTERNAL MEDICINE, 2007, 46 (02) : 101 - 103
  • [43] Non-alcoholic fatty liver disease
    Carreras, MP
    Tortajada, GC
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (05) : 377 - 377
  • [44] Non-alcoholic fatty liver disease
    Bjornsson, Einar
    Angulo, Paul
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (09) : 1023 - 1030
  • [45] Non-alcoholic fatty liver disease
    Cua, IHY
    George, J
    HOSPITAL MEDICINE, 2005, 66 (02): : 106 - 111
  • [46] Non-alcoholic fatty Liver disease
    Calderaro, Julien
    Zafrani, Elie Serge
    ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
  • [47] Non-alcoholic fatty liver disease
    Farrell, Geoffrey C.
    Wardell, Rebecca
    Teoh, Narci
    Chitturi, Shiv
    INTERNAL MEDICINE JOURNAL, 2019, 49 (05) : 681 - 683
  • [48] Non-alcoholic fatty liver disease
    Adams, LA
    Angulo, P
    LIVER DISEASES: ADVANCES IN TREATMENT AND PREVENTION: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 137 : 250 - 270
  • [49] Non-Alcoholic Fatty Liver Disease
    Engin, Atilla
    OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467
  • [50] Non-alcoholic fatty liver disease
    Brent A. Neuschwander-Tetri
    BMC Medicine, 15